Skrinjar I, Brailo V,
Vidovic-Juras D, Vucicevic-Boras V, Milenovic A. Evaluation of pretreatment serum interleukin-6 and
tumor necrosis factor alpha as a potential biomarker for recurrence in patients
with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20 (4):e402-7.
doi:10.4317/medoral.20373
http://dx.doi.org/doi:10.4317/medoral.20373
|
1.
Ramos M, Benavente S, Giralt J. Management of squamous cell carcinoma of the
head and neck: updated European tretment recommendations. Expert Rev
Anticancer Ther. 2010;10:339-44. |
|
|
|
|
|
2.
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inßammation and
cancer: how hot is the link? Biochem Pharmacol. 2006;72:1605-21. |
|
|
|
|
|
3.
Osman TA, Costea DE, Johannessen AC. The use of salivary cytokines as a
screening tool for oral squamous cell carcinoma: A review of the literature.
J Oral Maxillofac Pathol. 2012;16:256-61. |
|
|
|
|
|
4.
Druzgal CH, Chen Z, Yeh NT, Thomas GR, Ondrey FG, Duffey DC, et al. A pilot
study of longitudinal serum cytokine and angiogenesis factor levels as
markers of therapeutic response and survival in patients with head and neck
squamous cell carcinoma. Head Neck. 2005;27:771-84. |
|
|
|
|
|
5.
St John MA, Li Y, Zhou X, Denny P, Ho CM. Montemagno C, et al. Interleukin 6
and interleukin 8 as a potential biomarkers for oral cavity and oropharyngeal
squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929-35. |
|
|
|
|
|
6.
Hoffmann TK, Sonkoly E, Homey B, Scheckenbach K, Gwosdz C, Bas M, et al.
Aberrant cytokine expression in serum of patients with adenoid cystic
carcinoma and squamous cell carcinoma of the head and neck. Head Neck.
2007;29:472-8. |
|
|
|
|
|
7.
Mojtahedi Z, Khademi B, Hashemo SB, Bagher SM, Ghasemi MA, Fattahi MJ, et al.
Serum Interleukine-6 Concentration, But Not Interleukine-18 is Associated
with Head and Neck Squamous Cell Carcinoma Progression. Pathol Oncol Res.
2011;17:7-10. |
|
|
|
|
|
8.
Riedel F, Zaiss I, Herzog D, Gtte K, Naim R, Hrmann K. Serum levels of
interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Anticancer Res. 2005;25:2761-5. |
|
|
|
|
|
9.
Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis
factor and its superfamily: 25 years later, a golden journey. Blood.
2012;119:651-65. |
|
|
|
|
|
10.
Andersson B, Lewin F, Lundgren J, Nilsson M, Rutquist LE, Lfgren S, et al.
Plasma tumor necrosis factor-α and C-reactive protein as biomarker for
survival in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol.
2014;140:515-9. |
|
|
|
|
|
11.
Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J.
Development of the World Health Organization (WHO) Community Periodontal
Index of Treatment Needs (CPITN). Int Dent J. 1982;32:281-91. |
|
|
|
|
|
12.
Michalaki V, Syrigos K, Charles P, Waxman J. Serum levels of IL-6 and
TNF-α correlate with clinicopathological features and patient survival
in patients with prostate cancer Br J Cancer. 2004;90:2312-6. |
|
|
|
|
|
13.
Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen
risk factors for use in multivariable analysis. J Clin Epidemiol.
1996;49:907-16. |
|
|
|
|
|
14.
Sato J, Ohuchi M, Abe K, Satoh T, Abe T, Yamazaki Y, et al. Correlation between
salivary interleukin-6 levels and early locoregional recurrence in patients
with oral squamous cell carcinoma. Head Neck. 2013;35:889-94. |
|
|
|
|
|
15.
Huang TY, Hsu LP, Wen YH, Huang TT, Chou YF, Lee CF, et al. Predictors of
locoregional recurrence in early stage oral cavity cancer with free surgical
margins. Oral Oncol. 2010;46:49-55. |
|
|
|
|
|
16.
PoWing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, et al. Prognostic
factors of clinically stage I an stage II oral tongue carcinoma-A comparative
study of stage, thickness, shape. growth pattern, invasive front malignancy
grading, Martinez-Gimeno score, and pathologic features. Head Neck.
2002;24:513-20. |
|
|
|
|
|
17.
Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, et al.
Expression of proimflammatory and proangiogenic cytokines in patients with
head and neck cancer. Clin Cancer Res. 1999;5:1369-79. |
|
|
|
|
|
18.
Kinoshita A, Tajiri H. Cancer and Inflammation: Suppress Inflammation, Suppress
Cancer?. J Transl Med Epidemiol. 2013;1:1004. |
|
|
|
|
|
19.
Roxburgh CS, McMillan DC. Role of systemic inflammatory response in
predicting survival in patients with primary operable cancer. Future Oncol.
2010;6:149-63. |
|
|
|
|
|
20.
Czerninski R, Basile JR, Kartin-Gabay T, Laviv A, Barak V. Cytokines and
tumor markers in potentially malignant disorders and oral squamous cell
carcinoma: a pilot study. Oral Dis. 2014;20:477-81. |
|
|
|
|
|
21.
Vučićević Boras V, Čikeš N, Lukač J, Virag M,
Cekić-Arambašin A. Salivary and serum interleukin 6 and basic
fibroblast growth factor levels in patients with oral squamous cell
carcinoma. Minerva Stomatol. 2005;54:569-73. |
|
|
|
|
|
22.
Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al.
Interleukin-6 Predicts Recurrence and Survival Among Head and Neck Cancer
Patients. Cancer. 2008;113:750-7. |
|
|
|
|
|
23.
Gmş P, Nizam N, Lappin DF, Buduneli N. Saliva and serum levels of
B-cell activating factors and tumor necrosis factor-α in patients with
periodontitis. J Periodontol. 2014;85:270-80. |
|
|
|
|
|
24.
Allen C, Duffy S, Teknos T, Islam M, Chen Z, Albert PS. Nuclear
factor-kB-related serum factors as longitudinal biomarkers of response and
survival in advanced oropharyngeal carcinoma. Clin Cancer Res.
2007;13:3182-90. |
|
|
|
|
|
25.
Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell
carcinoma of the oral cavity in young people-a comprehensive literature
review. Oral Oncol. 2001;37:401-18. |
|
|
|
|
|
26.
Woolgar JA. Histopathological prognosticators in oral and oropharyngeal
squamous cell carcinoma. Oral Oncol. 2006;42:229-39. |
|
|
|
|
|
27.
Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B,
et al. Early detection of head and neck cancer: development of a novel
screening tool using multiplexed immunobead-based biomarker profiling. Cancer
Epidemiol Biomarkers Prev. 2007;16:102-7. |
|
|
|
|